NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 181 filers reported holding NOVAVAX INC in Q1 2016. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $82,000 | -98.1% | 39,600 | -93.4% | 0.02% | -98.9% |
| Q2 2016 | $4,381,000 | +35.3% | 602,750 | -4.0% | 2.20% | +39.9% |
| Q1 2016 | $3,239,000 | -40.2% | 627,750 | -2.8% | 1.57% | -26.6% |
| Q4 2015 | $5,417,000 | +22.8% | 645,650 | +3.5% | 2.14% | +21.5% |
| Q3 2015 | $4,411,000 | -33.7% | 623,950 | +2.0% | 1.76% | -21.9% |
| Q2 2015 | $6,658,000 | +30.5% | 611,950 | -0.8% | 2.25% | +20.2% |
| Q1 2015 | $5,102,000 | +44.7% | 616,950 | +3.8% | 1.88% | +38.7% |
| Q4 2014 | $3,526,000 | +70.9% | 594,650 | +20.1% | 1.35% | +67.1% |
| Q3 2014 | $2,063,000 | -12.3% | 494,950 | -2.8% | 0.81% | -3.9% |
| Q2 2014 | $2,353,000 | +2.5% | 509,450 | +0.5% | 0.84% | -8.1% |
| Q1 2014 | $2,296,000 | +455.9% | 506,950 | +528.2% | 0.92% | +435.7% |
| Q4 2013 | $413,000 | +86.0% | 80,700 | +14.1% | 0.17% | +51.3% |
| Q3 2013 | $222,000 | – | 70,700 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |